Pazopanib is an oral targeted drug, and standardized administration, reasonable management of missed doses, and dosage adjustments are the core to ensure efficacy and safety. The following provides concise guidelines from three aspects: administration methods, handling of missed doses, and dosage adjustments.
1、 Usage method
1. Medication time and fasting requirements
It should be taken on an empty stomach, 1 hour before or 2 hours after meals.
Swallow the whole piece, do not crush or chew.
2. Regular frequency of use
Once a day, it is recommended to take it at the same time every day to maintain stable blood drug concentration.
3. Avoid food affecting absorption
A high-fat diet can significantly increase drug absorption, potentially raising blood drug concentrations and toxicity risks, so it is essential to strictly adhere to fasting requirements.
2、 Handling of missed services
1. Rules for replenishing missed services
If it is less than 12 hours before the regular medication time, it can be taken immediately, and the next time it will still be taken at the original time.
If it has exceeded 12 hours, skip this missed dose and take it on time for the next time. Do not double the dosage.
2. Handling of special circumstances
If vomiting occurs after taking the medication, it is not recommended to increase the dosage and wait for the next dose according to the usual time.
3、 Dose adjustment
1. Standard starting and adjustment criteria
The recommended starting dose is 800mg/day.
Dose adjustment should be based on tolerance factors such as liver function, blood pressure, and skin reactions on hands and feet. The doctor should decide to gradually reduce the dosage (such as 400mg/day) and should not increase or decrease it on their own.
2. Interactions with other drugs
When used in combination with potent CYP3A4 inhibitors (such as clarithromycin) or inducers (such as rifampicin), the dosage should be reassessed by a doctor to avoid self combination.
3. Dosage principles for patients with liver function impairment
For patients with mild to moderate liver function impairment, it is recommended to reduce dosage or use with caution. For those with severe impairment, it is generally not recommended to use. The specific plan must strictly follow the doctor's advice.
Disclaimer:《Guidelines for taking Pazopanib》Edited and sorted by Seagull Pharmacy's editors. Please contact us in time if there is any infringement. In addition, the suggestions for drug usage, dosage and disease mentioned in the article are only for medical staff's reference, and can not be used as any basis for medication!
Full Name:pazopanib、Votrient、帕唑帕尼、培唑帕尼、维全特
Reference Price:$925.00
Prescribing Information: 在中国,帕唑帕尼于2017年3月3日获得批准上市;国家药品监督管理局NMPA批准帕唑帕尼用于一线治疗晚期肾细胞癌患者以及接受过细胞因子治疗的晚期肾癌患者。 一、药品名称 1、通用名:帕唑帕尼(pazopanib) 2、商品名:VOTRIENT 二、适应症 ...